Literature DB >> 16533962

Benign tremulous parkinsonism.

Keith A Josephs1, Joseph Y Matsumoto, J Eric Ahlskog.   

Abstract

BACKGROUND: Benign tremulous parkinsonism has never been precisely defined nor has the long-term course been studied.
OBJECTIVE: To report the clinical features and longitudinal course of patients with benign tremulous parkinsonism encountered in our movement disorders practice.
DESIGN: Computer search of medical records database.
SETTING: Mayo Clinic, Rochester, Minn. PATIENTS: Of 116 patients identified, 16 (10 male and 6 female) had at least an 8-year history of this disease, had been examined by a senior movement disorders specialist, and had ultimately been diagnosed as having benign tremulous parkinsonism after an initial diagnosis of Parkinson disease (PD).
INTERVENTIONS: None. MAIN OUTCOME MEASURES: Age at onset of disease, response to levodopa therapy, tremor characteristics, and family history.
RESULTS: Mean disease duration was 11 years (range, 8-25 years) at last follow-up. Mean age at onset, 58.5 years, was younger than in most PD series, and most patients had a poor levodopa response (although levodopa trials were inadequate in some). A moderate to marked postural tremor was noted in 13 of the 16 patients, including 6 with a kinetic tremor. A family history of PD and/or tremor was reported in 10 (63%) of our patients. Three patients required thalamic deep brain surgery to treat their tremor.
CONCLUSIONS: Benign tremulous parkinsonism may be a distinct clinical entity characterized by tremor predominance plus minimal progression of other aspects of parkinsonism. The tremor is often not very responsive to levodopa therapy. In this series, most patients had immediate family members with a diagnosis of tremor or PD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16533962     DOI: 10.1001/archneur.63.3.354

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  29 in total

1.  Morphological differences in Parkinson's disease with and without rest tremor.

Authors:  David H Benninger; Sebastian Thees; Spyros S Kollias; Claudio L Bassetti; Daniel Waldvogel
Journal:  J Neurol       Date:  2009-02-04       Impact factor: 4.849

2.  Motor imagery evokes increased somatosensory activity in Parkinson's disease patients with tremor.

Authors:  Rick C Helmich; Bastiaan R Bloem; Ivan Toni
Journal:  Hum Brain Mapp       Date:  2011-06-14       Impact factor: 5.038

Review 3.  Essential pitfalls in "essential" tremor.

Authors:  Alberto J Espay; Anthony E Lang; Roberto Erro; Aristide Merola; Alfonso Fasano; Alfredo Berardelli; Kailash P Bhatia
Journal:  Mov Disord       Date:  2017-01-24       Impact factor: 10.338

4.  Parkinson's Disease Revealed by a Resting Tongue Tremor.

Authors:  Paul Jaulent; Chloe Laurencin; Henri Robert; Stephane Thobois
Journal:  Mov Disord Clin Pract       Date:  2015-08-24

5.  Motor subtype changes in early Parkinson's disease.

Authors:  Robert S Eisinger; Christopher W Hess; Daniel Martinez-Ramirez; Leonardo Almeida; Kelly D Foote; Michael S Okun; Aysegul Gunduz
Journal:  Parkinsonism Relat Disord       Date:  2017-07-21       Impact factor: 4.891

6.  Neuroanatomical correlates of the inhibition of tremulous jaw movements in rats by a combination of memantine and Δ9 -tetrahydrocannabinol.

Authors:  Ilya D Ionov; Irina I Pushinskaya; David D Frenkel; Niсholas P Gorev; Larissa A Shpilevaya
Journal:  Br J Pharmacol       Date:  2020-01-24       Impact factor: 8.739

7.  Accuracy of nigrosome-1 detection to discriminate patients with Parkinson's disease and essential tremor.

Authors:  Manuel S Perez Akly; Carla V Stefani; Lucía Ciancaglini; José S Bestoso; Jorge A Funes; Diego J Bauso; Cristina H Besada
Journal:  Neuroradiol J       Date:  2019-05-31

8.  Deep brain stimulation for levodopa-refractory benign tremulous parkinsonism.

Authors:  Takuya Konno; Owen A Ross; Robert E Wharen; Ryan J Uitti; Zbigniew K Wszolek
Journal:  Neurol Neurochir Pol       Date:  2016-06-24       Impact factor: 1.621

9.  Role of LINGO1 polymorphisms in Parkinson's disease.

Authors:  Dietrich Haubenberger; Christoph Hotzy; Walter Pirker; Regina Katzenschlager; Thomas Brücke; Fritz Zimprich; Eduard Auff; Alexander Zimprich
Journal:  Mov Disord       Date:  2009-12-15       Impact factor: 10.338

10.  The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor.

Authors:  Maria C Ledesma; Elena García-Martín; Hortensia Alonso-Navarro; Carmen Martínez; Félix Javier Jiménez-Jiménez; Julián Benito-León; Inmaculada Puertas; Lluisa Rubio; Tomás López-Alburquerque; José A G Agúndez
Journal:  Neuromolecular Med       Date:  2008-06-10       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.